FI972306A0 - Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and methods for their use - Google Patents

Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and methods for their use

Info

Publication number
FI972306A0
FI972306A0 FI972306A FI972306A FI972306A0 FI 972306 A0 FI972306 A0 FI 972306A0 FI 972306 A FI972306 A FI 972306A FI 972306 A FI972306 A FI 972306A FI 972306 A0 FI972306 A0 FI 972306A0
Authority
FI
Finland
Prior art keywords
arylcarbonyloxymethyl
thiadiazolidin
substituted
compositions
methods
Prior art date
Application number
FI972306A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI972306A (en
Inventor
Ranjit C Desai
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of FI972306A0 publication Critical patent/FI972306A0/en
Publication of FI972306A publication Critical patent/FI972306A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08—Bridged systems
FI972306A 1994-12-02 1997-05-30 Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-onei-1,1-diozide derivatives and these containing compositions and methods for their use FI972306A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/349,341 US5556909A (en) 1994-12-02 1994-12-02 Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
PCT/US1995/015504 WO1996016951A1 (en) 1994-12-02 1995-11-30 Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof

Publications (2)

Publication Number Publication Date
FI972306A0 true FI972306A0 (en) 1997-05-30
FI972306A FI972306A (en) 1997-05-30

Family

ID=23371974

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972306A FI972306A (en) 1994-12-02 1997-05-30 Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-onei-1,1-diozide derivatives and these containing compositions and methods for their use

Country Status (12)

Country Link
US (1) US5556909A (en)
EP (1) EP0801648A4 (en)
JP (1) JPH10509979A (en)
CN (1) CN1173175A (en)
AU (1) AU703622B2 (en)
CA (1) CA2205837A1 (en)
FI (1) FI972306A (en)
HU (1) HUT77364A (en)
MX (1) MX9704034A (en)
NO (1) NO972449L (en)
NZ (1) NZ298266A (en)
WO (1) WO1996016951A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420401B1 (en) * 1997-08-22 2002-07-16 Wichita State University 1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives
GT200000203A (en) 1999-12-01 2002-05-24 COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND ELONGATION OF NEURONS.
US7405234B2 (en) * 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
GB0225986D0 (en) * 2002-11-07 2002-12-11 Astrazeneca Ab Chemical compounds
US7632858B2 (en) * 2002-11-15 2009-12-15 Bristol-Myers Squibb Company Open chain prolyl urea-related modulators of androgen receptor function
WO2004062664A1 (en) * 2002-12-30 2004-07-29 Vertex Pharmaceuticals Incorporated Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders
US7256208B2 (en) * 2003-11-13 2007-08-14 Bristol-Myers Squibb Company Monocyclic N-Aryl hydantoin modulators of androgen receptor function
US7820702B2 (en) * 2004-02-04 2010-10-26 Bristol-Myers Squibb Company Sulfonylpyrrolidine modulators of androgen receptor function and method
US20050182105A1 (en) * 2004-02-04 2005-08-18 Nirschl Alexandra A. Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function
US7388027B2 (en) * 2004-03-04 2008-06-17 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
US7625923B2 (en) * 2004-03-04 2009-12-01 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
US7696241B2 (en) * 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
WO2020219720A1 (en) * 2019-04-23 2020-10-29 The Cleveland Clinic Foundation Allosteric activators of the alpha1a -adrenergic receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128339A (en) * 1990-11-01 1992-07-07 Sterling Winthrop Inc. Proteolytic enzyme inhibition method
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
DE4141218A1 (en) * 1991-12-13 1993-06-17 Luitpold Werk Chem Pharm THIADIAZINCARBONE ACIDAMIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5550139A (en) * 1994-01-03 1996-08-27 The Wichita State University Serine protease inhibitors

Also Published As

Publication number Publication date
WO1996016951A1 (en) 1996-06-06
EP0801648A4 (en) 1998-01-28
EP0801648A1 (en) 1997-10-22
CN1173175A (en) 1998-02-11
NO972449D0 (en) 1997-05-29
AU703622B2 (en) 1999-03-25
CA2205837A1 (en) 1996-06-06
NO972449L (en) 1997-07-22
US5556909A (en) 1996-09-17
AU4371096A (en) 1996-06-19
NZ298266A (en) 1998-11-25
FI972306A (en) 1997-05-30
HUT77364A (en) 1998-03-30
JPH10509979A (en) 1998-09-29
MX9704034A (en) 1998-02-28

Similar Documents

Publication Publication Date Title
BR9711970A (en) 6,5-substituted-heterobicyclic derivatives
EE03741B1 (en) Use of the R-enantiomer of N-propargyl-1-aminoindan, its salts and compositions
FI970310A (en) 4-Indole derivatives as serotonin agents and antagonists
EE9500064A (en) Substituted 1H-imidazoles, methods for their preparation, and pharmaceutical compositions
DE69516018T2 (en) THICKENED PERSONIC COMPOSITION
FI941137A (en) 2-Debenzoyl-2-acyltaxol derivatives and methods for their preparation
NO952854D0 (en) 1-arylpyrimidin derivatives
DK0925298T3 (en) Substituted 6,6-heterobicyclic derivatives
FI972309A0 (en) 2-Heterocyclyloxy and thiomethyl-1,2,5-thiadizolidin-3-one 1,1-dioxides, compositions containing them and process for their preparation
DE59508427D1 (en) 3-ARYL-4-HYDROXY-DELTA 3 -DIHYDROTHIOPHENONE DERIVATIVES
BR9508844A (en) Oral composition
FI963566A0 (en) New piperazine derivatives, methods for their preparation and compositions containing them
BR9506536A (en) Oral composition
ATE231847T1 (en) SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALINE DERIVATIVES
EE200100347A (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
DE69430587D1 (en) PYRIMIDINE-ACYCLONUKLEOSID DERIVATIVES
FI972306A0 (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and methods for their use
IS4321A (en) New dialkoxy-pyridinyl-benzimidazole derivatives
FI955679A0 (en) Piperidine derivatives, their preparation and use
BR9507892A (en) New diamino-methylidene derivatives
FI971317A0 (en) New heterocyclic, substituted imidazoloquinoxalinones, their preparation and use
DE59509209D1 (en) DIPHENYLOXAZOLINE DERIVATIVES
BR9509877A (en) New pyrimidinyloxy-and pyridimidinylamino-ethylphenyl-dioxolane derivatives
DE69510792D1 (en) NAPHTOCHINONE DERIVATIVES
FI972307A0 (en) 2- (2,3,5,6-Tetrafluoro-4-pyridyl) -1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and methods for their use